DH DEFINITIVE HEALTHCARE CORP

Definitive Healthcare to Present at the Stifel 2023 Cross Sector Insight Conference and the 43rd Annual William Blair Growth Stock Conference

Definitive Healthcare to Present at the Stifel 2023 Cross Sector Insight Conference and the 43rd Annual William Blair Growth Stock Conference

FRAMINGHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the Stifel 2023 Cross Sector Insight Conference in Boston, MA and the 43rd Annual William Blair Growth Stock Conference in Chicago, IL.

  • Founder and Executive Chairman, Jason Krantz, will present at the Stifel Conference on Tuesday, June 6, 2023 at 1:15 PM Eastern Time and will be webcast live.



  • Chief Executive Officer, Robert Musslewhite, and Chief Financial Officer, Rick Booth, will present at the William Blair Conference on Wednesday, June 7, 2023 at 4:40 PM Central Time (5:40 PM Eastern Time) and will be webcast live.

A live webcast of each presentation will be available on the Events page of the Definitive Healthcare investor relations website at . A replay of each webcast will also be available for a limited time.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at .

Investor Relations Contact:

Brian Denyeau

ICR for Definitive Healthcare



646-277-1251

Media Contacts:

Danielle Johns



EN
31/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEFINITIVE HEALTHCARE CORP

 PRESS RELEASE

Definitive Healthcare Announces Timing of Its First Quarter 2025 Finan...

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event...

 PRESS RELEASE

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,...

 PRESS RELEASE

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare’s new Chief Customer Officer an inducement award consisting of 172,414 time-...

 PRESS RELEASE

Definitive Healthcare Reports Financial Results for Fourth Quarter and...

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 Fourth quarter and full year 2024 revenue exceeded guidance FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.  Fourth Quarter 2024 Financial Highlights: Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023. Net Loss, inclusive of goodwill imp...

 PRESS RELEASE

Definitive Healthcare to Present at the Raymond James 2025 Institution...

Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the Raymond James 2025 Institutional Investors Conference. The Definitive Healthcare presentation is scheduled for Tuesday, March 4, 2025, at 3:25 p.m. Eastern Time. A live webcast of the presentati...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch